10x Genomics, Inc.
MX ˙ BMV ˙ US88025U1097
SecurityMX:TXG / 10x Genomics, Inc.
InstitutionProShare Advisors LLC
Latest Disclosed Ownership21,565 shares
Latest Disclosed Value $ 457,825
ProShare Advisors LLC reports 14.85% decrease in ownership of TXG / 10x Genomics, Inc.

On April 24, 2026 - ProShare Advisors LLC filed a 13F-HR form disclosing ownership of 21,565 shares of 10x Genomics, Inc. (MX:TXG) valued at $457,825 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 6, 2026 disclosing 25,325 shares of 10x Genomics, Inc.. This represents a change in shares of -14.85% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-24 2026-03-31 13F 10X GENOMICS CL A COM 88025U109 21,565 -3,760 -14.85 458 10.65 0.0007
2026-02-06 2025-12-31 13F 10X GENOMICS CL A COM 88025U109 25,325 2,908 12.97 413 57.63 0.0007
2025-11-06 2025-09-30 13F 10X GENOMICS CL A COM 88025U109 22,417 -3,386 -13.12 262 -12.08 0.0005
2025-08-07 2025-06-30 13F 10X GENOMICS CL A COM 88025U109 25,803 25,803 299 0.0006
2022-05-10 2022-03-31 13F 10X GENOMICS CL A COM 88025U109 0 -2,300 -100.00 0 -100.00
2022-02-08 2021-12-31 13F 10X GENOMICS CL A COM 88025U109 2,300 152 7.08 343 9.58 0.0007
2021-11-12 2021-09-30 13F 10X GENOMICS CL A COM 88025U109 2,148 -534 -19.91 313 -40.38 0.0009
2021-08-13 2021-06-30 13F 10X GENOMICS CL A COM 88025U109 2,682 1,307 95.05 525 110.84 0.0015
2021-05-14 2021-03-31 13F 10X GENOMICS CL A COM 88025U109 1,375 1,375 249 0.0008
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.